The influenzadiagnostics market is expected to
reach USD 3.3 billion by 2024, according to a new report by Grand View
Research, Inc. Influenza, or "the flu," is an infectious disease and
affects the upper respiratory tract in humans. The disease is common in
children and elderly population (aged 65 years and above). The disease has a
huge impact on public health. Influenza A virus poses a greater risk as compared
to the influenza B virus. The B virus is responsible for 20% to 25% of
infections globally. The growth in the influenza diagnostic market is
attributed to factors such as emergence of technologically advanced diagnostic
tests with shorter turnaround time; initiatives by regulatory bodies, such as
CDC’s seasonal influenza vaccination for prevention and control of seasonal
influenza; and the demand created for influenza diagnosis in the flu season.
Rapid Influenza Diagnostic Tests (RIDTs)
accounted for the largest share in 2015. RIDTs are tests that deliver accurate
results in approximately 15 minutes. This factor deems them efficient, which
has resulted in the lucrative growth of this segment with the fastest CAGR.
Reverse transcription polymerase chain reaction (RT-PCR) holds the second
highest market share following RIDTs, and this can be attributed to the fact
that it provides detailed analytical results, sharper turnaround times, and
high throughput.
Hospitals held the highest market share in
2015, but Point-of-Care Testing (POCT) is anticipated to overtake and lead the
market in the coming future, owing to the increasing usage of POCT because of
its ease of use and short turnaround times.
North America dominates the market, due to
a high focus of the government and healthcare bodies to control influenza.
Browse full report by Grand View
Research : http://www.grandviewresearch.com/industry-analysis/influenza-diagnostics-market
Further Key Findings From the Study Suggest:
·
North America is anticipated to dominate
the global influenza diagnostics market. The high adoption rates of in vitro
diagnostics and presence of technologically advanced medical devices is
expected to drive growth in the region.
·
The Asia Pacific region is anticipated to
be the fastest growing region in the study period. This growth is attributed to
factors such as increasing initiatives by the countries to counter the
incidence of the disease. For instance, CDC reached a cooperative agreement
with South-East Asian Region to fund non research-related bilateral influenza
as a measure to respond to avian, seasonal, and pandemic influenza.
·
The RIDT segment is expected to grow at a
significant rate compared to others and accounts for the largest share in 2015.
·
This market comprises several local as well
as global players. Some of the major players of this vertical include Becton,
Dickinson and Company, Roche Diagnostics, Alere, Quidel Corporation, and Thermo
Fisher Scientific.
Browse more reports of this category by Grand View
Research: https://www.grandviewresearch.com/industry/clinical-diagnostics
Grand View Research has segmented the
influenza diagnostics market on the basis of test type, end use, and region:
Test Type Outlook (Revenue, USD Million, 2013
- 2024)
·
RIDTs
·
RT-PCR
·
Cell Culture
·
Others
End-use Outlook (Revenue, USD Million, 2013 - 2024)
·
Hospital
·
Point-of-Care Testing
·
Laboratories
Regional Outlook (Revenue, USD Million, 2013 - 2024)
·
North America
o U.S.
o Canada
·
Europe
o Germany
o UK
·
Asia Pacific
o China
o India
·
Latin America
o Brazil
o Mexico
·
MEA
o South Africa
o Saudi Arabia
View press
release of this research report by Grand View Research: https://www.grandviewresearch.com/press-release/global-influenza-diagnostics-market
About Grand
View Research
Grand View Research, Inc. is a U.S. based market research and consulting
company, registered in the State of California and headquartered in San
Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed
business decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
